XML 48 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2

9. Segment and Geographic Information (Details - Product license fees) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Product license fees and royalties	$ 75,000	$ 339,000	$ 150,000	$ 786,000
Exeltis [Member]
Product license fees and royalties	0	103,000	0	157,000
Innovacyn [Member]
Product license fees and royalties	0	9,000	0	29,000
Laboratorios Sanfer [Member]
Product license fees and royalties	$ 75,000	$ 227,000	$ 150,000	$ 600,000

X

- Definition

Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_LicensesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ocls_ExeltisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ocls_InnovacynMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=ocls_LaboratoriosSanferMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: